Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-01

Clinical Trial Update: A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing insulin detemir versus insulin NPH in children/adolescents with type 2 diabetes inadequately controlled on metformin, with or without ba…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin detemir (insulin detemir)
  • insulin NPH (insulin NPH)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED | Results posted: 2017-09-01